Literature DB >> 14507352

Signalling mechanism coupled to 5-hydroxytryptamine4 receptor-mediated facilitation of fast synaptic transmission in the guinea-pig ileum myenteric plexus.

J J Galligan1, H Pan, E Messori.   

Abstract

5-hydroxytryptamine (HT)4 receptor agonists stimulate gastrointestinal motility partly by facilitating acetylcholine release from myenteric neurones. However, the signalling mechanisms that couple 5-HT4 receptor activation to increased transmitter release in the myenteric plexus are unknown. We used conventional intracellular electrophysiological methods to record fast excitatory postsynaptic potentials (fEPSPs) from neurones in the guinea-pig ileum myenteric plexus preparation. The substituted benzamide, renzapride, acted at 5-HT4 receptors to facilitate fEPSPs. This response was mimicked by forskolin, an activator of adenylate cyclase. Facilitation of fEPSPs by renzapride and forskolin was not blocked by treating tissues with pertussis toxin (PTX) (2 h, 2 microg mL-1). Facilitation of fEPSPs caused by renzapride was blocked by the non-selective protein kinase inhibitors, staurosporine (1 micromol L-1) and H-8 (30 micromol L-1) and by the selective protein kinase A (PKA) inhibitor, H-89 (10 micromol L-1). These data indicate that 5-HT4 receptors act via a PTX-resistant mechanism to activate PKA. Protein kinase A activation leads to an increase in transmitter release from myenteric nerve terminals and a facilitation of fast excitatory synaptic transmission.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14507352     DOI: 10.1046/j.1365-2982.2003.00428.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  19 in total

1.  Synaptic plasticity in myenteric neurons of the guinea-pig distal colon: presynaptic mechanisms of inflammation-induced synaptic facilitation.

Authors:  Eric M Krauter; David R Linden; Keith A Sharkey; Gary M Mawe
Journal:  J Physiol       Date:  2007-03-15       Impact factor: 5.182

Review 2.  Serotonin and neuroprotection in functional bowel disorders.

Authors:  M D Gershon; M-T Liu
Journal:  Neurogastroenterol Motil       Date:  2007-08       Impact factor: 3.598

3.  Synaptic transmission at functionally identified synapses in the enteric nervous system: roles for both ionotropic and metabotropic receptors.

Authors:  R M Gwynne; J C Bornstein
Journal:  Curr Neuropharmacol       Date:  2007-03       Impact factor: 7.363

4.  Enteric Nervous System: Neuropathic Gastrointestinal Motility.

Authors:  Jackie D Wood
Journal:  Dig Dis Sci       Date:  2016-07       Impact factor: 3.199

Review 5.  Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets.

Authors:  Gary M Mawe; Jill M Hoffman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-06-25       Impact factor: 46.802

Review 6.  The role of serotonin in irritable bowel syndrome: implications for management.

Authors:  Brian Garvin; John W Wiley
Journal:  Curr Gastroenterol Rep       Date:  2008-08

7.  Paradoxical regulation of ChAT and nNOS expression in animal models of Crohn's colitis and ulcerative colitis.

Authors:  John H Winston; Qingjie Li; Sushil K Sarna
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-05-16       Impact factor: 4.052

Review 8.  Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity.

Authors:  Elena F Verdu; David Armstrong; Joseph A Murray
Journal:  Am J Gastroenterol       Date:  2009-06       Impact factor: 10.864

9.  5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice.

Authors:  Min-Tsai Liu; Yung-Hui Kuan; Jingwen Wang; René Hen; Michael D Gershon
Journal:  J Neurosci       Date:  2009-08-05       Impact factor: 6.167

10.  5-HT4 receptor activation facilitates recovery from synaptic rundown and increases transmitter release from single varicosities of myenteric neurons.

Authors:  Jianhua Ren; Xiaoping Zhou; James J Galligan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-04-24       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.